These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 11543692)

  • 1. Allergen-specific sublingual immunotherapy for respiratory allergy.
    Passalacqua G; Canonica GW
    BioDrugs; 2001; 15(8):509-19. PubMed ID: 11543692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of allergen-specific sublingual immunotherapy and nasal immunotherapy.
    Passalacqua G; Fumagalli F; Guerra L; Canonica GW
    Chem Immunol Allergy; 2003; 82():109-18. PubMed ID: 12947997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.
    O'Hehir RE; Sandrini A; Anderson GP; Rolland JM
    Curr Med Chem; 2007; 14(21):2235-44. PubMed ID: 17896972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen immunotherapy for respiratory allergy: to what extent can the risk of systemic reactions be reduced?
    Incorvaia C; Pucciarini F; Makri E; Gritti BL; Ridolo E
    Expert Opin Drug Saf; 2020 Jul; 19(7):843-848. PubMed ID: 32511028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose dependence of efficacy but not of safety in sublingual immunotherapy.
    Frati F; Incorvaia C; Marcucci F; Sensi L; Di Cara G; Puccinelli P; Dal Bo S
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):38-40. PubMed ID: 16700192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen-specific Immunotherapy for Inhalant Allergens in Children.
    Caffarelli C; Cangemi J; Mastrorilli C; Giannetti A; Ricci G
    Curr Pediatr Rev; 2020; 16(2):129-139. PubMed ID: 31642784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy for treating respiratory allergy: a review on its effectiveness and suitability.
    Incorvaia C; Fuiano N; Leo G
    Clin Ter; 2010; 161(6):543-7. PubMed ID: 21181085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.
    Passalacqua G; Canonica GW; Bagnasco D
    Curr Allergy Asthma Rep; 2016 Nov; 16(12):88. PubMed ID: 27957697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-injection routes for allergen immunotherapy: focus on sublingual immunotherapy.
    Passalacqua G; Guerra L; Pasquali M; Canonica GW
    Inflamm Allergy Drug Targets; 2006 Jan; 5(1):43-51. PubMed ID: 16613563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more.
    Marogna M; Spadolini I; Massolo A; Canonica GW; Passalacqua G
    Allergy; 2004 Nov; 59(11):1205-10. PubMed ID: 15461603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninjection routes for immunotherapy.
    Canonica GW; Passalacqua G
    J Allergy Clin Immunol; 2003 Mar; 111(3):437-48; quiz 449. PubMed ID: 12642818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes.
    Incorvaia C; Ciprandi G; Nizi MC; Makri E; Ridolo E
    Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):245-257. PubMed ID: 32372588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
    J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One century of allergen-specific immunotherapy for respiratory allergy.
    Incorvaia C; Frati F
    Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunotherapy in preschool children: an update.
    Vitaliti G; Pavone P; Guglielmo F; Falsaperla R
    Expert Rev Clin Immunol; 2013 Apr; 9(4):385-90. PubMed ID: 23557273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of immunotherapy in allergic rhinitis.
    Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 27658025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis investigating the efficacy and safety of allergen-specific immunotherapy in the management of respiratory allergies.
    Li X; Shang J; Liu J; Zhu Y
    J Asthma; 2024 Oct; 61(10):1337-1346. PubMed ID: 38687911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.